mDPR-Val-Cit-PAB-MMAE
Modify Date: 2024-01-16 19:47:05
mDPR-Val-Cit-PAB-MMAE structure
|
Common Name | mDPR-Val-Cit-PAB-MMAE | ||
|---|---|---|---|---|
| CAS Number | 1491152-26-1 | Molecular Weight | 1289.561 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 1353.3±65.0 °C at 760 mmHg | |
| Molecular Formula | C65H100N12O15 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 772.3±34.3 °C | |
Use of mDPR-Val-Cit-PAB-MMAEmDPR-Val-Cit-PAB-MMAE consists the ADCs linker (mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE), mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate. |
| Name | mDPR-Val-Cit-PAB-MMAE |
|---|---|
| Synonym | More Synonyms |
| Description | mDPR-Val-Cit-PAB-MMAE consists the ADCs linker (mDPR-Val-Cit-PAB) and potent tubulin inhibitor (MMAE), mDPR-Val-Cit-PAB-MMAE is an antibody drug conjugate. |
|---|---|
| Related Catalog |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 1353.3±65.0 °C at 760 mmHg |
| Molecular Formula | C65H100N12O15 |
| Molecular Weight | 1289.561 |
| Flash Point | 772.3±34.3 °C |
| Exact Mass | 1288.743164 |
| LogP | 4.57 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.566 |
| Storage condition | 2-8℃ |
| N-[(2S)-3-Amino-2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]-L-valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2 ;-methyl-3-oxopropyl]-1-pyrrolidinyl}-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N5-carbamoyl-L-ornithinamide |
| L-Ornithinamide, N-[(2S)-3-amino-2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxopropyl]-L-valyl-N5-(aminocarbonyl)-N-[4-[(5S,8S,11S,12R)-12-[2-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenyl ethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-oxoethyl]-4,10-dimethyl-5,8-bis(1-methylethyl)-11-[(1S)-1-methylpropyl]-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl]- |